RASNA THERAPEUTICS, INC. (OTCMKTS:RASP) Files An 8-K Other Events
Item 8.01
| Other Events. |
On April12, 2017, Rasna Therapeutics, Inc. issued a press release
announcing that it has qualified and is now trading on the OTCQX
Best Market, operated by OTC Markets Group).
The press release is attached as Exhibit99.1 to this report on
Form8-K and is incorporated herein by reference.
| Item 9.01. | Financial Statements and Exhibits. |
| (d) | Exhibits. |
| 99.1 | Rasna Therapeutics, Inc. Press Release dated April12, 2017. |
–
–
About RASNA THERAPEUTICS, INC. (OTCMKTS:RASP)
Rasna Therapeutics, Inc., formerly Active With Me Inc., creates online resources that offer travelers information on activity-based travel. The Company’s Website focuses on offering third-party content and information to visitors in their activity of choice. The Company’s Website also focuses on offering links to clubs and organizations. The Company is in development-stage. Rasna DE is the subsidiary of the Company. Rasna DE is engaged in modulating the molecular targets nucleophosmin gene (NPM1) and lysine (K)-specific demethylase 1A (LSD1), which are implicated in the disease progression of leukemia and lymphoma. The Company focuses on performing preclinical research on NPM1 and LSD1. As of June 30, 2016, the Company had not generated any revenues. RASNA THERAPEUTICS, INC. (OTCMKTS:RASP) Recent Trading Information
RASNA THERAPEUTICS, INC. (OTCMKTS:RASP) closed its last trading session 00.000 at 0.850 with shares trading hands.
